Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
Clinical trial NCT00004249 · COMPLETED
Trial details
- NCT number
- NCT00004249
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 2001-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.